Skip to content

Investigating the effect of two types of time restricted eating on glycemic, lipid indices, appetite, and sleep quality of women with polycystic ovary syndrome

Investigating the effect of two types of time restricted eating on glycemic, lipid indices, appetite, and sleep quality of women with polycystic ovary syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221122056575N1
Enrollment
75
Registered
2022-12-24
Start date
2022-11-10
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: People in the intervention groups will have a time-restricted eating of the type (14:10), in which people in the early time restricted eating (eTRE) group will be i

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age 18 - 40 years 25 = body mass index(BMI) = 34.9 Women with PCOS diagnosed by the Rotterdam criteria

Exclusion criteria

Exclusion criteria: pregnant or lactating night-shift workers, hypotension use of medication therapy that impacts carbohydrate or lipid metabolism (oral contraceptive pills, insulin-sensitizers, antiepileptics, statins, fish oil and ...) in the recent 3 months body weight fluctuations for more than 5% in the past 3 months Medicines that affect body weight Regular use of any drug or supplement that affects sleep Taking drugs that affect appetite at the time of entering the study Having a special diet Eating disorders or mental disorders night eating syndrome fasting for more than 14 h per day Congenital adrenal hyperplasia, androgen-secreting tumor, Cushing's syndrome, diabetes, thyroid dysfunction and hyperprolactinemia Cardiovascular, kidney, liver, lung and nervous diseases, digestive system surgery or food absorption disorders professional athlete perimenopausal Tobacco history Taking food supplements Sarcopenia

Design outcomes

Primary

MeasureTime frame
Fasting Blood Sugar. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Fasting Insulin. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Insulin resistance. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Calculation of Homeostatic Model Assessment (HOMA).;Total cholesterol. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Triglyceride. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;High-density lipoprotein (HDL). Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Low-density lipoprotein (LDL). Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Appetite. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: Visual Analog Scale (VAS) questionnaire.;Sleep quality. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Petersburg’s sleep quality questionnaire.;Body weight. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: scale.;Waist circumference. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Meter.;Body mass index (BMI). Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Weight in kilograms divided by height squared in meters.

Secondary

MeasureTime frame
Body composition. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Bioelectric Impedance Analysis (BIA) device.;Eating behavior. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: The Three-Factor Eating Questionnaire.;Energy intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall.;Carbohydrate intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall.;Protein intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall.;Fat intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSevana Daneghian

Oroumia University of Medical Sciences

Sevana_d@yahoo.com+98 44 3223 4897

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026